These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19002696)

  • 1. Carbon dioxide does not affect the methylation status of prognostic important oncogenes Rassf1A and DCR2 in neuroblastoma cells.
    Reismann M; Lehmann D; Quandte M; Ure BM; Glüer S
    Pediatr Surg Int; 2008 Dec; 24(12):1327-30. PubMed ID: 19002696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of RASSF1A, DCR2, and CASP8 Methylation with Survival in Neuroblastoma: A Pooled Analysis Using Reconstructed Individual Patient Data.
    Hassan WM; Bakry MS; Siepmann T; Illigens B
    Biomed Res Int; 2020; 2020():7390473. PubMed ID: 33381579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors.
    Michalowski MB; de Fraipont F; Plantaz D; Michelland S; Combaret V; Favrot MC
    Pediatr Blood Cancer; 2008 Jan; 50(1):29-32. PubMed ID: 17570703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating methylated-DCR2 gene in serum as an indicator of prognosis and therapeutic efficacy in patients with MYCN nonamplified neuroblastoma.
    Yagyu S; Gotoh T; Iehara T; Miyachi M; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tamura S; Tsuchiya K; Imamura T; Misawa-Furihata A; Sugimoto T; Sawada T; Hosoi H
    Clin Cancer Res; 2008 Nov; 14(21):7011-9. PubMed ID: 18980997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASSF1A methylation may have two biological roles in neuroblastoma tumorigenesis depending on the ploidy status and age of patients.
    Haruta M; Kamijo T; Nakagawara A; Kaneko Y
    Cancer Lett; 2014 Jun; 348(1-2):167-76. PubMed ID: 24680815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon dioxide, hypoxia and low pH lead to overexpression of c-myc and HMGB-1 oncogenes in neuroblastoma cells.
    Reismann M; Wehrmann F; Schukfeh N; Kuebler JF; Ure B; Glüer S
    Eur J Pediatr Surg; 2009 Aug; 19(4):224-7. PubMed ID: 19387923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome.
    Yang Q; Kiernan CM; Tian Y; Salwen HR; Chlenski A; Brumback BA; London WB; Cohn SL
    Clin Cancer Res; 2007 Jun; 13(11):3191-7. PubMed ID: 17545522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation.
    van Noesel MM; van Bezouw S; Salomons GS; Voûte PA; Pieters R; Baylin SB; Herman JG; Versteeg R
    Cancer Res; 2002 Apr; 62(7):2157-61. PubMed ID: 11929838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.
    Yang Q; Zage P; Kagan D; Tian Y; Seshadri R; Salwen HR; Liu S; Chlenski A; Cohn SL
    Clin Cancer Res; 2004 Dec; 10(24):8493-500. PubMed ID: 15623630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors.
    Banelli B; Gelvi I; Di Vinci A; Scaruffi P; Casciano I; Allemanni G; Bonassi S; Tonini GP; Romani M
    Oncogene; 2005 Aug; 24(36):5619-28. PubMed ID: 16044164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker.
    Misawa A; Tanaka S; Yagyu S; Tsuchiya K; Iehara T; Sugimoto T; Hosoi H
    Br J Cancer; 2009 Jan; 100(2):399-404. PubMed ID: 19165202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to carbon dioxide and helium reduces in vitro proliferation of pediatric tumor cells.
    Schmidt AI; Reismann M; Kübler JF; Vieten G; Bangen C; Shimotakahara A; Glüer S; Nustede R; Ure BM
    Pediatr Surg Int; 2006 Jan; 22(1):72-7. PubMed ID: 16283335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clustering of hypermethylated genes in neuroblastoma.
    van Noesel MM; van Bezouw S; Voûte PA; Herman JG; Pieters R; Versteeg R
    Genes Chromosomes Cancer; 2003 Nov; 38(3):226-33. PubMed ID: 14506696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.
    Shivapurkar N; Toyooka S; Toyooka KO; Reddy J; Miyajima K; Suzuki M; Shigematsu H; Takahashi T; Parikh G; Pass HI; Chaudhary PM; Gazdar AF
    Int J Cancer; 2004 May; 109(5):786-92. PubMed ID: 14999791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
    Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CO2 Pneumoperitoneum Effects on Molecular Markers of Tumor Invasiveness in SH-SY5Y Neuroblastoma Cells.
    Montalto AS; Currò M; Russo T; Ferlazzo N; Caccamo D; Ientile R; Romeo C; Impellizzeri P
    Eur J Pediatr Surg; 2020 Dec; 30(6):524-528. PubMed ID: 31707727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic alterations in sporadic basal cell carcinomas.
    Stamatelli A; Vlachou C; Aroni K; Papassideri I; Patsouris E; Saetta AA
    Arch Dermatol Res; 2014 Aug; 306(6):561-9. PubMed ID: 24573469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A; Dallol A; Zöchbauer-Müller S; Morrissey C; Honorio S; Hesson L; Martinsson T; Fong KM; Kuo MJ; Yuen PW; Maher ER; Minna JD; Latif F
    Oncogene; 2003 Mar; 22(10):1580-8. PubMed ID: 12629521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of aberrant DNA methylation with clinicopathological features in breast cancer.
    Tserga A; Michalopoulos NV; Levidou G; Korkolopoulou P; Zografos G; Patsouris E; Saetta AA
    Oncol Rep; 2012 May; 27(5):1630-8. PubMed ID: 22159596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells.
    Zuo S; Chen Y; Xu L; Tang Q; Zou S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):281-4. PubMed ID: 17641842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.